propofol has been researched along with Angiogenesis, Pathologic in 4 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Cao, B | 1 |
| Ji, P | 1 |
| Yao, F | 1 |
| Gao, Y | 1 |
| Yu, X | 1 |
| Zhang, F | 1 |
| Dai, J | 1 |
| Xu, YB | 2 |
| Du, QH | 1 |
| Zhang, MY | 1 |
| Yun, P | 1 |
| He, CY | 1 |
| Guo, XG | 1 |
| Wang, S | 1 |
| Zhuang, J | 1 |
4 other studies available for propofol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Propofol inhibits tumor angiogenesis through targeting VEGF/VEGFR and mTOR/eIF4E signaling.
Topics: A549 Cells; Angiogenesis Inhibitors; Cell Proliferation; Eukaryotic Initiation Factor-4E; HCT116 Cel | 2021 |
Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8.
Topics: ADAM Proteins; Animals; Antigens, CD; Biomarkers, Tumor; Blotting, Western; Cell Hypoxia; Cell Line, | 2019 |
Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Esophageal Neoplasm | 2013 |
Propofol suppresses invasion, angiogenesis and survival of EC-1 cells in vitro by regulation of S100A4 expression.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relation | 2015 |